Healthineers did better than expected by us and clearly beat consensus (top-line: +10.2%; profitability: +20.5%). The strong development was primary driven by the diagnostics boom, which made Healthineer a strong and obligatory player. Like every boom, the effect will phase out in the coming quarters. Varian, the new kid on the bloc, made the expected strong contribution, whereas the other divisions reported the usual temporary volatility.